Advances in the interpretation and prediction of CYP2E1 metabolism from a biochemical perspective

Bibliography

• Guengerich FP, Kim DH, Iwasaki M. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 1991;4:168-79
   PubMed Web of Science ®Google Scholar
• Rendic S. Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev 2002;34:83-448
   PubMed Web of Science ®Google Scholar
• Koop DR, Morgan ET, Tarr GE, Coon MJ. Purification and characterization of a unique isozyme of cytochrome P-450 from liver microsomes of ethanol-treated rabbits. J Biol Chem 1982;257:8472-80
   PubMed Web of Science ®Google Scholar
• Robertson G, Leclercq I, Farrell GC. Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol 2001;281:G1135-9
   PubMed Web of Science ®Google Scholar
• Lewis D, Bird MG, Parke DV. Molecular modelling of CYP2E1 enzymes from rat, mouse and man: an explanation for species differences in butadiene metabolism and potential carcinogenicity, and rationalization of CYP2E substrate specificity. Toxicology 1997;118:93-113
   PubMed Web of Science ®Google Scholar
• Ronis M, Lindros KO, Ingelman-Sundberg M. The CYP2E1 subfamily. Chapter 9. In: Ioannides C, editor. Cytochromes P450 – metabolic and toxicological aspects. CRC Press; 1996. p. 211-39
   Google Scholar
• Caro AA, Cederbaum AI. Oxidative stress, toxicology, and pharmacology of CYP2E1. Ann Rev Pharmacol Toxicol 2004;44:27-42
   PubMed Web of Science ®Google Scholar
• Atkins W. Non-Michaelis-Menten kinetics in cytochrome P450-catalyzed reactions. Ann Rev Pharmacol Toxicol 2005;45:291-310
   PubMed Web of Science ®Google Scholar
• Koop DR. Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P-450 isozyme 3a. Mol Pharmacol 1986;29:399-404
   PubMed Web of Science ®Google Scholar
• Collom SL, Laddusaw RM, Burch AM, et al. CYP2E1 substrate inhibition: mechanistic interpretation through an effector site for monocyclic compounds. J Biol Chem 2008;283:3487-96
   PubMed Web of Science ®Google Scholar
• Hargreaves MB, Jones BC, Smith DA, Gescher A. Inhibition of p-nitrophenol hydroxylase in rat liver microsomes by small aromatic and heterocyclic molecules. Drug Metab Dis 1994;22:806-10
   PubMed Web of Science ®Google Scholar
• Harrelson JP, Atkins WM, Nelson SD. Multiple-ligand binding in CYP2A6: probing mechanisms of cytochrome P450 cooperativity by assessing substrate dynamics. Biochemistry 2008;47:2978-88
   PubMed Web of Science ®Google Scholar
• Harrelson J, Henne KR, Alonso DOV, Nelson SD. A comparison of substrate dynamics in human CYP2E1 and CYP2A6. Biochem Biophys Res Commun 2007;352:843-9
   PubMed Web of Science ®Google Scholar
• Cohen G, Mannering GJ. Involvement of a hydrophobic site in the inhibition of the microsomal p-hydroxylation of aniline by alcohols. Mol Pharmacol 1973;9:383-97
   PubMed Web of Science ®Google Scholar
• Webb J. Enzyme and metabolic inhibitors. Volume 1. New York: Academic Press; 1963
   Google Scholar
• Koop DR, Coon MJ. Ethanol oxidation and toxicity: role of alcohol P-450 oxygenase. Alcohol Clin Exp Res 1986;10:S44-9
   PubMed Web of Science ®Google Scholar
• Wang M, Wade D, Chen LS, et al. Probing the active sites of rat and human cytochrome-P450 2E1 with alcohols and carboxylic acids. Arch Biochem Biophys 1995;317:299-304
   PubMed Web of Science ®Google Scholar
• Bellec G, Dreano Y, Lozach P, et al. Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes. Carcinogenesis 1996;17:2029-34
   PubMed Web of Science ®Google Scholar
• Bauer C, Osman AM, Cercignani G, et al. A unified theory of enzyme kinetics based upon the systematic analysis of the variations of kcat, KM, and kcat/KM and the relevant [Delta]G0[not equal to] values - possible implications in chemotherapy and biotechnology. Biochem Pharmacol 2001;61:1049-55
   PubMed Web of Science ®Google Scholar
• Lewis D, Modi S, Dickins M. Structure-activity relationship for human cytochrome P450 substrates and inhibitors. Drug Metab Rev 2002;34:69-82
   PubMed Web of Science ®Google Scholar
• Lewis D, Sams C, Loizou GD. A quantitative structure-activity relationship analysis on a series of alkyl benzenes metabolized by human cytochrome P450 2E1. J Biochem Mol Toxicol 2003;17:47-52
   PubMed Web of Science ®Google Scholar
• Song BJ, Gelboin HV, Park SS, et al. Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P-450s: transcriptional and post-transcriptional regulation of the rat enzyme. J Biol Chem 1986;261:16689-97
   PubMed Web of Science ®Google Scholar
• Umeno M, McBride OW, Yang C-S, et al. Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosome mapping, and cDNA-directed expression. Biochemistry 1988;27:9006-13
   PubMed Web of Science ®Google Scholar
• Hu Y, Oscarson M, Johansson I, et al. Genetic polymorphism of human CYP2E1: characterization of two variant alleles. Mol Pharmacol 1997;51:370-6
   PubMed Web of Science ®Google Scholar
• Fairbrother KS, Grove J, de Waziers I, et al. Detection and characterization of novel polymorphisms in the CYP2E1 gene. Pharmacogenetics 1998;8:543-52
   PubMedGoogle Scholar
• Hanioka N, Tanaka-Kagawa T, Miyata Y, et al. Functional characterization of three human cytochrome P450 2E1 variants with amino acid substitutions. Xenobiotica 2003;33:575-86
   PubMed Web of Science ®Google Scholar
• Gotoh O. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analysis of amino acid and coding nucleotide sequences. J Biol Chem 1992;267:83-90
   PubMed Web of Science ®Google Scholar
• Radi R, Peluffo G, Alvarez MN, et al. Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med 2001;30:463-88
   PubMed Web of Science ®Google Scholar
• Greenacre S, Ischiropoulos H. Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Radic Res 2001;34:541-81
   PubMed Web of Science ®Google Scholar
• Turko IV, Murad F. Protein nitration in cardiovascular diseases. Pharmacol Rev 2002;54:619-34
   PubMed Web of Science ®Google Scholar
• Lin H-L, Myshkin E, Waskell L, Hollenberg PF. Peroxynitrite inactivation of human cytochrome P450s 2B6 and 2E1: heme modification and site-specific nitrotyrosine formation. Chem Res Toxicol 2007;20:1612-22
   PubMed Web of Science ®Google Scholar
• Mackman R, Guo Z, Guengerich FP, Ortiz de Montellano PR. Active site topology of human cytochrome P450 2E1. Chem Res Toxicol 1996;9:223-6
   PubMed Web of Science ®Google Scholar
• Gartner CA. Photoaffinity ligands in the study of cytochrome P450 active site structure. Curr Med Chem 2003;10:671-89
   PubMed Web of Science ®Google Scholar
• Born SL, Caudill D, Fliter KL, Purdon MP. Identification of the cytochromes P450 that catalyze coumarin 3,4-epoxidation and 3-hydroxylation. Drug Metab Dis 2002;30:483-7
   PubMed Web of Science ®Google Scholar
• Collom SL, Jamakhandi AP, Tackett AJ, et al. CYP2E1 active site residues in substrate recognition sequence 5 identified by photoaffinity labeling and homology modeling. Arch Biochem Biophys 2007;459:59-69
   PubMed Web of Science ®Google Scholar
• Domanski TL, Halpert JR. Analysis of mammalian cytochrome P450 structure and function by site-directed mutagenesis. Curr Drug Metab 2001;2:117-37
   PubMed Web of Science ®Google Scholar
• Guengerich F. Rate-limiting steps in cytochrome P450 catalysis. Biol Chem 2002;383:1553-64
   PubMed Web of Science ®Google Scholar
• Vaz ADN, McGinnity DF, Coon MJ. Epoxidation of olefins by cytochrome P450: evidence from site-specific mutagenesis for hydroperoxo-iron as an electrophilic oxidant. Proc Natl Acad Sci USA 1998;95:3555-60
   PubMed Web of Science ®Google Scholar
• Fukuda T, Imai Y, Komori M, et al. Replacement of Thr-303 of P450 2E1 with serine modifies the regioselectivity of its fatty acid hydroxylase activity. J Biochem (Tokyo) 1993;113:7-12
   PubMed Web of Science ®Google Scholar
• Blobaum AL, Kent UM, Alworth WL, Hollenberg PF. Mechanism-based inactivation of cytochromes P450 2E1 and 2E1 T303A by tert-butyl acetylenes: characterization of reactive intermediate adducts to the heme and apoprotein. Chem Res Toxicol 2002;15:1561-71
   PubMed Web of Science ®Google Scholar
• Blobaum AL, Kent UM, Alworth WL, Hollenberg PF. Novel reversible inactivation of cytochrome P450 2E1 T303A by tert-butyl acetylene: the role of threonine 303 in proton delivery to the active site of cytochrome P450 2E1. J Pharmacol Exp Ther 2004;310:281-90
   PubMed Web of Science ®Google Scholar
• Tan Y, White SP, Paranawithana SR, Yang CS. A hypothetical model for the active site of human cytochrome P450 2E1. Xenobiotica 1997;27:287-99
   PubMed Web of Science ®Google Scholar
• Lewis DFV. Homology modelling of human CYP2 family enzymes based on the CYP2C5 crystal structure. Xenobiotica 2002;32:305-23
   PubMedGoogle Scholar
• Imai Y, Fukuda T, Komori M, Nakamura M. Comparison of heme environment at the putative distal region of P-450s utilizing their external and internal nitrogenous ligand bound forms. Biochim Biophys Acta 1994;1207:49-57
   PubMed Web of Science ®Google Scholar
• Nelson DR, Strobel HW. On the membrane topology of vertebrate cytochrome P-450 proteins. J Biol Chem 1988;263:6038-50
   PubMed Web of Science ®Google Scholar
• Porter TD. Mutagenesis at a highly conserved phenylalanine in cytochrome P450 2E1 affects heme incorporation and catalytic activity. Biochemistry 1994;33:5942-6
   PubMed Web of Science ®Google Scholar
• Spatzenegger M, Liu H, Wang Q, et al. Analysis of differential substrate selectivities of CYP2B6 and CYP2E1 by site-directed mutagenesis and molecular modeling. J Pharmacol Exp Ther 2003;304:477-87
   PubMed Web of Science ®Google Scholar
• Hasemann CA, Kurumbail RG, Boddupalli SS, et al. Structure and function of cytochromes P450: a comparative analysis of three crystal structures. Structure 1995;3:41-62
   PubMed Web of Science ®Google Scholar
• Mestres J. Structure conservation in cytochromes P450. Proteins: Struct Funct Bioinf 2005;58:596-609
   PubMed Web of Science ®Google Scholar
• Park J-Y, Harris D. Construction and assessment of models of CYP2E1: predictions of metabolism from docking, molecular dynamics, and density functional theoretical calculations. J Med Chem 2003;46:1645-60
   PubMed Web of Science ®Google Scholar
• Burley S, Petsko GA. Weakly polar interactions in proteins. Adv Protein Chem 1988;39:125-89
   PubMedGoogle Scholar
• Anzenbacherova E, Hudecek J, Murgida D, et al. Active sites of two orthologous cytochromes P450 2E1: differences revealed by spectroscopic methods. Biochem Biophys Res Commun 2005;338:477-82
   PubMed Web of Science ®Google Scholar
• Smith SV, Koley AP, Dai R, et al. Conformational modulation of human cytochrome P450 2E1 by ethanol and other substrates: a CO flash photolysis study. Biochemistry 2000;39:5731-7
   PubMed Web of Science ®Google Scholar
• Smith S, Robinson RC, Smith TG, et al. Rapid conformational dynamics of cytochrome P450 2E1 in a natural biological membrane environment. Biochemistry 2006;45:15617-23
   PubMed Web of Science ®Google Scholar
• Bell LC, Guengerich FP. Oxidation kinetics of ethanol by human cytochrome P450 2E1. Rate-limiting product release accounts for effects of isotopic hydrogen substitution and cytochrome b5 on steady-state kinetics. J Biol Chem 1997;272:29643-51
   PubMed Web of Science ®Google Scholar
• Kuliopulos A, Mildvan AS, Shortle D, Talalay P. Kinetic and ultraviolet spectroscopic studies of active-site mutants of d5-3-ketosteroid isomerase. Biochemistry 1989;28:149-59
   PubMed Web of Science ®Google Scholar
• Wells JA. Additivity of mutational effects in proteins. Biochemistry 1990;29:8509-17
   PubMed Web of Science ®Google Scholar
• Delaforge M, Pruvost A, Perrin L, Andre F. Cytochrome P450-mediated oxidation of glucuronide derivatives: examples of estradiol-17β-glucuronide oxidation to 2-hydroxy-estradiol-17β-glucuronide by CYP2C8. Drug Metab Dis 2005;33:466-73
   PubMed Web of Science ®Google Scholar
• PyMOL. Available from: http://pymol.sourceforge.net
   Google Scholar